Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.
Status:
Completed
Trial end date:
2020-10-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects on urothelial cancer of nab-paclitaxel
compared to paclitaxel to treat this disease.
This research is being done because currently there is no effective treatment for urothelial
cancer that has progressed after prior chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Canadian Cancer Trials Group
Collaborators:
Australian and New Zealand Urogenital and Prostate Cancer Trials Group Celgene